Companies / TScan Therapeutics, Inc. / Activity
Activity — TScan Therapeutics, Inc.
7 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| May 20, 2026 | Baker Bros. Advisors LP Director | Grant | Non- Qualified Stock Option (right to buy) | — | +67K | 67,000 0.10% of shares | low |
| May 20, 2026 | Baker Bros. Advisors LP Director | Grant | Non- Qualified Stock Option (right to buy) | — | +67K | 67,000 0.10% of shares | low |
| Jan 20, 2026 | Amello Jason Executive | Grant | Stock Option (Right to Buy) | — | +350K | 350,000 0.52% of shares | low |
| Jan 20, 2026 | MacBeath Gavin CEO | Grant | Stock Option (Right to Buy) | — | +1.2M | 1,165,000 1.72% of shares | low |
| Jan 20, 2026 | Dworak Leiden Executive | Grant | Stock Option (Right to Buy) | — | +100K | 100,000 0.15% of shares | low |
| Jan 20, 2026 | Louis Chrystal Executive | Grant | Stock Option (Right to Buy) | — | +420K | 420,000 0.62% of shares | low |
| Jan 20, 2026 | Zdraveski Zoran Executive | Grant | Stock Option (Right to Buy) | — | +350K | 350,000 0.52% of shares | low |